Italia markets closed

INCY Mar 2024 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,0000+0,0500 (+5,26%)
In data: 01:23PM EST. Mercato aperto.
Schermo intero
Chiusura precedente0,9500
Aperto1,4000
Denaro0,8000
Lettera1,0000
Prezzo d'esercizio62,50
Scadenza2024-03-15
Min-Max giorno1,0000 - 1,4000
Contratto - Min-MaxN/D
Volume29
Open Interest550
  • GlobeNewswire

    Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

    PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic

  • GlobeNewswire

    Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil

    MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for pemigatinib to ANVISA, the Brazilian health regulatory agency, under the rare diseases approval pathway, for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor recepto